Skip Navigation
NCI banner National Cancer Institute U.S. National Institutes of Health National Cancer Institute
Chromosomes
  • Tools
  • Genetic and Physical SNP Maps
  • SNP500Cancer
Cancer Genome Characterization Initiative

Visit the database of genomic characterization data for multiple tumor types.

Association List

Go to page: 1 2 [Full Text] NextPage
Displaying Investigations 1 to 100 of 146 found
From 18 References


Andersson et al 2015, Nat Genet
  Acute lymphoblastic leukemia/lymphoblastic lymphoma
SETD2/CCDC12
t(3;3)(p21;p21)
B-Lineage

Asmann et al 2012, Cancer Res
  Adenocarcinoma Breast
RBM6/SLC38A3
t(3;3)(p21;p21)

Bueno et al 2016, Nat Genet
  Mesothelioma Pleura
PBRM1/BAP1
t(3;3)(p21;p21)
  Mesothelioma Pleura
SETD2/NBEAL2
t(3;3)(p21;p21)
  Mesothelioma Pleura
NBEAL2/SETD2
t(3;3)(p21;p21)
  Mesothelioma Pleura
PBRM1/CYB561D2
t(3;3)(p21;p21)

Frattini et al 2013, Nat Genet
  Astrocytoma, grade III-IV/Glioblastoma Brain
ARIH2/CAMP
t(3;3)(p21;p21)

Gu et al 2016, Nat Commun
  Acute lymphoblastic leukemia/lymphoblastic lymphoma
SETD2/CCDC12
t(3;3)(p21;p21)
B-Lineage
  Acute lymphoblastic leukemia/lymphoblastic lymphoma
SETD2/CCDC12
t(3;3)(p21;p21)
B-Lineage

Hu et al 2018, Nucleic Acids Res
  Squamous cell carcinoma Lung
ALAS1/PARP3
t(3;3)(p21;p21)
  Adenocarcinoma Uterus, corpus
ALAS1/RBM6
t(3;3)(p21;p21)
  Malignant melanoma Skin
BAP1/PBRM1
t(3;3)(p21;p21)
  Mesothelioma Pleura
BAP1/PLXNB1
t(3;3)(p21;p21)
  Astrocytoma, grade I-II Brain
BAP1/DNAH1
t(3;3)(p21;p21)
  Adenocarcinoma Oesophagus
CACNA1D/GNL3
t(3;3)(p21;p21)
  Adenocarcinoma Uterus, corpus
CDC25A/SLC26A6
t(3;3)(p21;p21)
  Malignant melanoma Skin
CDC25A/RBM6
t(3;3)(p21;p21)
  Adenocarcinoma Uterus, corpus
CHDH/ACTR8
t(3;3)(p21;p21)
  Adenocarcinoma Oesophagus
COL7A1/SLC26A6
t(3;3)(p21;p21)
  Adenocarcinoma Uterus, corpus
CYB561D2/RBM6
t(3;3)(p21;p21)
  Adenocarcinoma Liver
DAG1/LARS2
t(3;3)(p21;p21)
  Malignant epithelial tumor, special type Uterus, corpus
DALRD3/IMPDH2
t(3;3)(p21;p21)
  Adenocarcinoma Ovary
DHX30/NT5DC2
t(3;3)(p21;p21)
  Adenocarcinoma Prostate
DHX30/LIMD1
t(3;3)(p21;p21)
  Adenocarcinoma Prostate
DHX30/ZDHHC3
t(3;3)(p21;p21)
  Adenocarcinoma Stomach
DNAH1/CACNA1D
t(3;3)(p21;p21)
  Astrocytoma, grade I-II Brain
DOCK3/FAM212A
t(3;3)(p21;p21)
  Squamous cell carcinoma Lung
EXOSC7/ZDHHC3
t(3;3)(p21;p21)
  Mesothelioma Pleura
GLT8D1/PLXNB1
t(3;3)(p21;p21)
  Squamous cell carcinoma Lung
GNL3/MANF
t(3;3)(p21;p21)
  Mesothelioma Pleura
GNL3/BAP1
t(3;3)(p21;p21)
  Adenocarcinoma Oesophagus
IP6K1/UBA7
t(3;3)(p21;p21)
  Transitional cell carcinoma Bladder
IP6K1/MON1A
t(3;3)(p21;p21)
  Adenocarcinoma Prostate
IP6K1/HYAL3
t(3;3)(p21;p21)
  Adenocarcinoma Stomach
IP6K2/RHOA
t(3;3)(p21;p21)
  Transitional cell carcinoma Bladder
KLHL18/HEMK1
t(3;3)(p21;p21)
  Diffuse large B-cell lymphoma
LARS2/ANO10
t(3;3)(p21;p21)
  Adenocarcinoma Stomach
MAP4/SHISA5
t(3;3)(p21;p21)
  Adenocarcinoma Liver
MAP4/QRICH1
t(3;3)(p21;p21)
  Adenocarcinoma Uterus, corpus
MAP4/PLXNB1
t(3;3)(p21;p21)
  Transitional cell carcinoma Bladder
MAP4/NME6
t(3;3)(p21;p21)
  Squamous cell carcinoma Uterus, cervix
NCKIPSD/IP6K2
t(3;3)(p21;p21)
  Benign epithelial tumor, special type Thyroid
NCKIPSD/SFMBT1
t(3;3)(p21;p21)
  Adenocarcinoma Oesophagus
NISCH/DNAH1
t(3;3)(p21;p21)
  Mesothelioma Pleura
NME6/NT5DC2
t(3;3)(p21;p21)
  Squamous cell carcinoma Uterus, cervix
NME6/SPINK8
t(3;3)(p21;p21)
  Squamous cell carcinoma Unknown site
PBRM1/GLT8D1
t(3;3)(p21;p21)
  Mesothelioma Pleura
PBRM1/FBXW12
t(3;3)(p21;p21)
  Squamous cell carcinoma Unknown site
PCBP4/POC1A
t(3;3)(p21;p21)
  Mesothelioma Pleura
PLXNB1/ITIH3
t(3;3)(p21;p21)
  Adenocarcinoma Liver
PLXNB1/SLC26A6
t(3;3)(p21;p21)
  Adenocarcinoma Uterus, corpus
POC1A/TWF2
t(3;3)(p21;p21)
  Benign epithelial tumor, special type Thyroid
PRKAR2A/CACNA2D3
t(3;3)(p21;p21)
  Adenocarcinoma Prostate
PRKAR2A/CACNA1D
t(3;3)(p21;p21)
  Adenocarcinoma Lung
PTPN23/KLHL18
t(3;3)(p21;p21)
  Adenocarcinoma Stomach
PTPN23/RTP3
t(3;3)(p21;p21)
  Diffuse large B-cell lymphoma
QRICH1/C3orf62
t(3;3)(p21;p21)
  Adenocarcinoma Liver
QRICH1/TRAIP
t(3;3)(p21;p21)
  Adenocarcinoma Liver
QRICH1/USP4
t(3;3)(p21;p21)
  Adenocarcinoma Stomach
RBM6/RNF123
t(3;3)(p21;p21)
  Squamous cell carcinoma Lung
RBM6/FAM212A
t(3;3)(p21;p21)
  Adenocarcinoma Uterus, corpus
RFT1/TKT
t(3;3)(p21;p21)
  Adenocarcinoma Breast
SCAP/ELP6
t(3;3)(p21;p21)
  Adenocarcinoma Oesophagus
SEMA3F/RNF123
t(3;3)(p21;p21)
  Mesothelioma Pleura
SETD2/NISCH
t(3;3)(p21;p21)
  Mesenchymal tumor, NOS Unknown site
SETD2/RBM6
t(3;3)(p21;p21)
  Adenocarcinoma Stomach
SETD2/SCAP
t(3;3)(p21;p21)
  Mesenchymal tumor, NOS Unknown site
SETD2/CCRL2
t(3;3)(p21;p21)
  Adenocarcinoma Stomach
SETD2/SMARCC1
t(3;3)(p21;p21)
  Mesothelioma Pleura
SFMBT1/ZDHHC3
t(3;3)(p21;p21)
  Adenocarcinoma Stomach
SFMBT1/TKT
t(3;3)(p21;p21)
  Squamous cell carcinoma Uterus, cervix
SHISA5/IP6K2
t(3;3)(p21;p21)
  Malignant melanoma Skin
SMARCC1/CDC25A
t(3;3)(p21;p21)
  Malignant epithelial tumor, special type Uterus, corpus
SMARCC1/DHX30
t(3;3)(p21;p21)
  Malignant epithelial tumor, special type Uterus, corpus
SMIM4/STAB1
t(3;3)(p21;p21)
  Adenocarcinoma Uterus, corpus
SMIM4/NISCH
t(3;3)(p21;p21)
  Adenocarcinoma Liver
TMEM110/RFT1
t(3;3)(p21;p21)
  Adenocarcinoma Pancreas
TUSC2/RASSF1
t(3;3)(p21;p21)
  Malignant epithelial tumor, special type Uterus, corpus
TWF2/ALAS1
t(3;3)(p21;p21)
  Squamous cell carcinoma Uterus, cervix
TWF2/WDR82
t(3;3)(p21;p21)
  Transitional cell carcinoma Bladder
UQCRC1/PRKAR2A
t(3;3)(p21;p21)
  Transitional cell carcinoma Bladder
USP4/RHOA
t(3;3)(p21;p21)
  Malignant epithelial tumor, special type Uterus, corpus
WDR82/GLT8D1
t(3;3)(p21;p21)

Lapuk et al 2012, J Pathol
  Adenocarcinoma Prostate
RAD54L2/VPRBP
t(3;3)(p21;p21)

Levin et al 2009, Genome Biol
  Chronic myeloid leukemia, t(9;22)
NCKIPSD/CELSR3
t(3;3)(p21;p21)

Liu et al 2016, EBioMedicine
  Acute lymphoblastic leukemia/lymphoblastic lymphoma
UQCRC1/ANO10
t(3;3)(p21;p21)
B-Lineage

Robinson et al 2017, Nature
  Germ cell tumor, special type Testis
SMARCC1/MAP4
t(3;3)(p21;p21)

Rudin et al 2012, Nat Genet
  Undifferentiated carcinoma, small cell Lung
NEK4/SFMBT1
t(3;3)(p21;p21)

Sato et al 2013, Nat Genet
  Adenocarcinoma Kidney
SETD2/QRICH1
t(3;3)(p21;p21)

Shah et al 2013, BMC Genomics
  Astrocytoma, grade III-IV/Glioblastoma Brain
ARIH2/CAMP
t(3;3)(p21;p21)
  Astrocytoma, grade III-IV/Glioblastoma Brain
PRKAR2A/SPINK8
t(3;3)(p21;p21)

Tao et al 2018, BMC Cancer
  Squamous cell carcinoma Larynx
COL7A1/UCN2
t(3;3)(p21;p21)

Wang et al 2014, Nat Genet
  Adenocarcinoma Stomach
RHOA/COL7A1
t(3;3)(p21;p21)

Wu et al 2012, J Pathol
  Adenocarcinoma Prostate
RAD54L2/VPRBP
t(3;3)(p21;p21)

Yoshihara et al 2015, Oncogene
  Malignant melanoma Skin
PBRM1/NEK4
t(3;3)(p21;p21)
  Adenocarcinoma Prostate
ZNF589/ALS2CL
t(3;3)(p21;p21)
  Adenocarcinoma Ovary
CDC25A/PRKAR2A
t(3;3)(p21;p21)
  Adenocarcinoma Prostate
SMARCC1/SPINK8
t(3;3)(p21;p21)
  Adenocarcinoma Prostate
MAP4/MON1A
t(3;3)(p21;p21)
  Adenocarcinoma Ovary
MAP4/CDC25A
t(3;3)(p21;p21)

NextPage